Share on LinkedInShare on LinkedIn

ARTICLE · 18 MAY 2026

Compensation For Unjust Preliminary Injunctions In Pharmaceutical Patents And Critical Parameters

Gün + Partners
Gün + Partners
Contributor
Gün + Partners

Gün + Partners

We are one of the oldest and largest law firms in Turkey and are considered internationally to be...

View firm profile
Explore more from Gün + Partners

One of the most complex types of disputes encountered in the field of pharmaceutical patents is compensation lawsuits arising from unjust preliminary injunctions.

TurkeyIntellectual Property

One of the most complex types of disputes encountered in the field of pharmaceutical patents is compensation lawsuits arising from unjust preliminary injunctions. These compensation lawsuits require meticulous assessment from the perspective of both procedural law and substantive law. Especially, because of the controversies over the nature of fault-based liability arising from the ambiguities in the wording of Article 399 of the Code of Civil Procedure (“CCP”), and where patent law, procedural law, competition law, and economic analyses intersect regarding, the calculation of lost profits suffered by generic pharmaceutical companies, the specific features of the concrete case play a decisive role.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from